Your browser doesn't support javascript.
loading
Validity of the Arabic International Physical Activity Questionnaire to Measure Moderate-to-Vigorous Physical Activity in People with Diabetes.
Al Ozairi, Ebaa; AlSaraf, Husain; Al-Ozairi, Abdullah; Hamdan, Yasmine; Al Esmaeel, Batool Camille; Alsaeed, Dalal; Abdalla, Mohamed; Gray, Stuart R.
Afiliación
  • Al Ozairi E; Clinical Research Unit, Dasman Diabetes Institute, Kuwait City, Kuwait.
  • AlSaraf H; Department of Medicine, Faculty of Medicine, Kuwait University, Kuwait City, Kuwait.
  • Al-Ozairi A; Clinical Research Unit, Dasman Diabetes Institute, Kuwait City, Kuwait.
  • Hamdan Y; Geriatrics and Neuropsychiatry Unit, Amiri Hospital, Kuwait City, Kuwait.
  • Al Esmaeel BC; Clinical Research Unit, Dasman Diabetes Institute, Kuwait City, Kuwait.
  • Alsaeed D; Department of Medicine, Faculty of Medicine, Kuwait University, Kuwait City, Kuwait.
  • Abdalla M; Clinical Research Unit, Dasman Diabetes Institute, Kuwait City, Kuwait.
  • Gray SR; Clinical Research Unit, Dasman Diabetes Institute, Kuwait City, Kuwait.
Diabetes Metab Syndr Obes ; 17: 3491-3498, 2024.
Article en En | MEDLINE | ID: mdl-39309310
ABSTRACT

Purpose:

The aim of this cross-sectional study was to compare the Arabic version of International Physical Activity Questionnaire (IPAQ) measured moderate-to-vigorous physical activity (MVPA) with accelerometer-measured MVPA in people with diabetes.

Methods:

From 2020 to 2022 physical activity was measured people ≥18 years with type 1 or type 2 diabetes in Kuwait. Self-reported MVPA was measured over 7 days with the Arabic version of the IPAQ. During the same 7-day period wrist worn accelerometers were used to objectively measure MVPA. IPAQ MVPA was calculated both including and excluding walking physical activity. MVPA measures were compared by limits of agreement approach, Pearson correlations and concordance correlations.

Results:

We recruited 240 participants with type 1 diabetes and 343 participants with type 2 diabetes for the study. In people with type 1 diabetes, there were no concordance correlations between IPAQ MVPA, both including (rho = -0.011 (-0.038, 0.017), p = 0.444) and excluding (rho = -0.001 (-0.067, 0.065), p = 0.978) walking physical activity. MVPA measured by IPAQ was 43.3(-85.6, 172.2) min/day higher than accelerometer-measured MVPA, when including walking, and 8.88(-60.4, 78.2) min/day higher, when excluding walking. In people with type 2 diabetes, there were significant positive concordance correlations between IPAQ MVPA, both including (rho = 0.038 (0.02, 0.06), p < 0.001) and excluding (rho = 0.34 (0.27, 0.41), p < 0.001) walking physical activity. MVPA measured by IPAQ was 62.3 (95% CI -61.5 to 186.0) min/day higher than accelerometer-measured MVPA, when including walking, and 4.0 (95% CI -34.1 to 42.0) min/day higher, when excluding walking.

Conclusion:

In people with type 1 or type 2 diabetes, caution should be exercised when using the Arabic version of the IPAQ to measure MVPA.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Diabetes Metab Syndr Obes Año: 2024 Tipo del documento: Article País de afiliación: Kuwait Pais de publicación: Nueva Zelanda

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Diabetes Metab Syndr Obes Año: 2024 Tipo del documento: Article País de afiliación: Kuwait Pais de publicación: Nueva Zelanda